0001628280-26-030923
SEC filingAflac reported a significant GAAP profitability rebound in Q1 2026, with net income rising to $1.0 billion from $29 million in the prior year period. The improvement was driven by a 27.9% increase in total revenues, reflecting a shift in investment results compared to the prior year's losses.
Aflac's first quarter 2026 results reflect a significant turnaround in reported GAAP profitability. Total revenues rose 27.9% to $4.3 billion, compared to $3.4 billion in the same period last year. The most notable shift occurred in net income, which increased to $1.0 billion from $29 million in the prior year period. This resulted in diluted EPS of $1.98, compared to $0.05 in Q1 2025.
The magnitude of the year-over-year percentage increase in profitability underscores the impact of the prior-year comparative period, which was weighed down by significant investment losses. The current quarter's results demonstrate the earnings capacity of the business when investment results normalize. Management's commentary emphasizes that profitability depends on actuarial and policyholder behavior experience, the ability to generate favorable investment results, and effective capital deployment.
The company's investment approach remains focused on disciplined asset and liability management. Management seeks to deliver stable income within regulatory and capital objectives while preserving shareholder value. A key component of this strategy involves managing currency risk, particularly given Aflac's substantial exposure to Japanese yen-denominated liabilities. The company utilizes amortized hedge costs and income to measure periodic currency risk management results, which management considers an important component of net investment income.
Looking forward, management maintains a constructive view on the Japanese market. With continued cost pressure on Japan's healthcare system, the company expects rising demand for third-sector products. Cancer and medical insurance products are expected to remain an important part of Aflac Japan's portfolio. The company also continues to manage its exposure to unhedged U.S. dollars in relation to its yen-denominated liabilities, optimizing for Bermuda Monetary Authority capital requirements.
The combination of normalized investment results, strong cash generation, and a favorable demographic outlook in its core market positions Aflac to maintain its focus on shareholder value creation through disciplined capital management.